Arcus Biosciences, Inc.
RCUS
$28.74
$0.020.07%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.94% | -17.55% | 0.31% | -23.69% | -5.99% |
| Total Receivables | 105.00% | -66.67% | -36.00% | -33.33% | -39.39% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -13.33% | 15.38% | -23.08% | -29.41% | -25.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -20.08% | -18.14% | -0.89% | -23.96% | -7.44% |
|
|
|||||
| Total Current Assets | -20.08% | -18.14% | -0.89% | -23.96% | -7.44% |
| Net Property, Plant & Equipment | -18.18% | -17.39% | -12.50% | -12.50% | -10.20% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -14.49% | -14.08% | -37.50% | -13.33% | -8.00% |
| Total Assets | -14.05% | -13.75% | -0.96% | -22.20% | -9.36% |
|
|
|||||
| Total Accounts Payable | 17.24% | 77.27% | 133.33% | 223.08% | 93.33% |
| Total Accrued Expenses | 45.12% | 62.32% | 27.08% | 33.33% | 41.38% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.33% | 8.33% | 8.33% | 18.18% | 9.09% |
| Total Finance Division Other Current Liabilities | -63.22% | -49.44% | -46.00% | -36.45% | -24.35% |
| Total Other Current Liabilities | -63.22% | -49.44% | -46.00% | -36.45% | -24.35% |
| Total Current Liabilities | -5.71% | 8.85% | 2.21% | 9.30% | 5.53% |
|
|
|||||
| Total Current Liabilities | -5.71% | 8.85% | 2.21% | 9.30% | 5.53% |
| Long-Term Debt | 90.68% | 217.39% | 73.91% | 75.00% | 490.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -13.13% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -81.31% | -87.64% | -73.80% | -54.46% | -7.48% |
| Total Liabilities | -12.55% | -24.32% | -23.61% | -21.69% | -4.54% |
|
|
|||||
| Common Stock & APIC | 20.97% | 20.45% | 30.86% | 13.30% | 13.34% |
| Retained Earnings | -36.98% | -29.66% | -31.18% | -32.85% | -31.50% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -15.48% | -1.32% | 30.10% | -22.83% | -13.54% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -15.48% | -1.32% | 30.10% | -22.83% | -13.54% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -15.48% | -1.32% | 30.10% | -22.83% | -13.54% |
|
|
|||||